Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NOTCH1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZNF184 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | RP11-290H9.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | ITPKA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | TMEM159 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | P2RX5 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | CD22 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | EGFL8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | INMT-FAM188B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | WDR12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |